Tulex Pharms Inc Company Profile
✉ Email this page to a colleague
What is the competitive landscape for TULEX PHARMS INC, and what generic and branded alternatives to TULEX PHARMS INC drugs are available?
TULEX PHARMS INC has five approved drugs.
Drugs and US Patents for Tulex Pharms Inc
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Tulex Pharms Inc | NAPROXEN | naproxen | TABLET, DELAYED RELEASE;ORAL | 216908-001 | May 31, 2023 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Tulex Pharms Inc | CLOMIPRAMINE HYDROCHLORIDE | clomipramine hydrochloride | CAPSULE;ORAL | 210653-001 | Apr 3, 2020 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Tulex Pharms Inc | CLOMIPRAMINE HYDROCHLORIDE | clomipramine hydrochloride | CAPSULE;ORAL | 210653-003 | Apr 3, 2020 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.